道恩股份(002838.SZ):擬設立道恩高分子材料(重慶)有限公司
格隆匯 2 月 24日丨道恩股份(002838.SZ)公佈,公司擬在重慶市江津區珞璜工業園投資設立全資子公司道恩高分子材料(重慶)有限公司,註冊資本為5000萬元。
根據公司與重慶市江津區珞璜工業園發展中心簽訂的《項目投資協議》,公司擬在珞璜工業園建設道恩高分子材料西南總部基地項目,項目建設內容為改性塑料等產品生產基地及研發中心。為保證項目的投資建設及運營管理,公司設立下屬子公司實施上述項目的投資、建設和運營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.